About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Arizona | 16,604 Studies Near You

Clinical TrialsArizona

Clinical Trials in Arizona

Discover 16,604 clinical trials near Arizona. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2861-2880 of 16,604 trials

UnknownPharmacogenomics of Heparin-Induced ThrombocytopeniaThe purpose of this research is to identify genomic markers that can predict heparin-induced thrombocytopenia (HIT), which is a very serious side effect to heparin.NCT02717039·Tucson, Arizona RecruitingREmote Virtual Inspiration: Vitality and EnergyREVIVE is a randomized controlled trial designed to evaluate the effects of a remotely delivered seated Tai Chi/Qigong (TCQ) intervention on cardiometabolic health, stress, sleep…NCT07675681·Phoenix, Arizona

Find Trials by Condition in Arizona

Breast Cancerin Arizona Lung Cancerin Arizona Prostate Cancerin Arizona Colorectal Cancerin Arizona Melanomain Arizona Leukemiain Arizona Lymphomain Arizona Pancreatic Cancerin Arizona Ovarian Cancerin Arizona Brain Cancerin Arizona Diabetes

Data from ClinicalTrials.govTerms

CompletedRituximab, Cladribine, and Temsirolimus in Treating Patients With Newly Diagnosed Mantle Cell LymphomaThis phase I/II trial studies the side effects and best dose of temsirolimus when given together with cladribine and rituximab and to see how well it works in treating patients…NCT00787969·Scottsdale, Arizona and 143 others

CompletedEfficacy and Safety Study of FP MDPI Compared With FS MDPI in Adolescent and Adult Patients With Persistent AsthmaThe primary objective of this study was to evaluate the efficacy of fluticasone propionate (Fp) multidose dry powder inhaler (MDPI) and fluticasone propionate/salmeterol xinafoate…NCT02141854·Birmingham, Alabama and 153 others

RecruitingTURN-IT FOG: Improving Turning and Freezing of Gait in People With PDThe goals of this clinical trial are to 1) learn how two different rehabilitation interventions for PD can reduce Freezing of Gait (FOG) in people with Parkinson's disease, as…NCT06815302·Tempe, Arizona and 2 others

CompletedCombination Chemotherapy, Radiation Therapy, and RSR13 in Treating Patients With Stage III Non-small Cell Lung CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00004202·Tucson, Arizona and 15 others

CompletedEfficacy and Safety in Patients With Type 2 Diabetes Mellitus and Cardiovascular DiseaseThis study is carried out to assess whether dapagliflozin improves glycemic control, decreases fasting plasma glucose levels, body weight and blood pressure when added to…NCT01042977·Birmingham, Alabama and 134 others

CompletedObservational Study to Evaluate PAD Treatment Clinical and Economic OutcomesThe purpose of this study is to evaluate acute and long term clinical and economic outcomes of endovascular procedures to treat Peripheral Arterial Disease (PAD).NCT01855412·Gilbert, Arizona and 51 others

CompletedComparison of NN1250 With Insulin Glargine Plus Insulin Aspart With/Without Metformin and With/Without Pioglitazone in Type 2 DiabetesThis trial is conducted in Africa, Asia, Europe, and the United States of America (USA).NCT00972283·Alexander City, Alabama and 135 others

CompletedMOTION, Safinamide in Early IPD, as add-on to Dopamine AgonistParkinson's disease is a major neurodegenerative disorder in which there is a progressive loss of nigrostriatal dopaminergic neurons.NCT00605683·Birmingham, Alabama and 124 others

CompletedA Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back PainThe primary objective is to assess the efficacy of oxycodone/naloxone controlled-release tablets (OXN) for the management of opioid-induced constipation (OIC) compared with…NCT01427283·Alabaster, Alabama and 148 others

CompletedAn Exploratory Study of XP21279 (With Lodosyn®) and Sinemet® in Parkinson's Disease SubjectsThe purpose of the study is to assess the pharmacokinetics, pharmacodynamics, and safety of XP21279 sustained release formulation \[administered with Lodosyn® (carbidopa)\] and…NCT00914602·Peoria, Arizona and 1 other

CompletedSafety Study to Determine the Maximum Tolerated Dose, Pharmacokinetics and Pharmacodynamics of Oral MP470, a Multitargeted Tyrosine Kinase Inhibitor, in Patients With Solid MalignanciesMulticenter, open-label, dose-ranging study in two parts: maximum tolerated dose (MTD) segment (the first 28-day course of MP 470) followed by long-term safety segment.NCT00894894·Scottsdale, Arizona and 1 other

TerminatedA Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema (DME)This Phase 3 study will evaluate the efficacy, durability, and safety of KSI-301 compared to aflibercept in participants with treatment-naïve DME.NCT04603937·Phoenix, Arizona and 71 others

CompletedTransthyretin Amyloidosis Outcome Survey (THAOS)THAOS is a global, multi-center, longitudinal observational survey open to all patients with transthyretin amyloidosis (ATTR), including ATTR-PN (polyneuropathy), ATTR-CM…NCT00628745·Birmingham, Alabama and 112 others

CompletedSWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ TransplantRATIONALE: Reducing the amount of drugs used to prevent transplant rejection may help a person's body kill tumor cells.NCT00002657·Mobile, Alabama and 85 others

CompletedEfficacy, Safety, and Tolerability of Ledipasvir/Sofosbuvir (LDV/SOF) Treatment for HIV/HCV Co-infected Participants Who Switch to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) or Emtricitabine/Rilpivirine/Tenofovir Alafenamide (F/R/TAF) Prior to LDV/SOF HCV TreatmentThis study will evaluate efficacy of ledipasvir/sofosbuvir (LDV/SOF) and safety and tolerability of switching to elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide…NCT02707601·Birmingham, Alabama and 42 others

TerminatedCoenzyme Q10 in Huntington's Disease (HD)The goals of this trial are to determine if coenzyme Q10 is effective in slowing the worsening symptoms of Huntington's disease and to learn about the safety and acceptability of…NCT00608881·Birmingham, Alabama and 48 others

CompletedEfficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients With Type 2 DiabetesThis is a pivotal phase III study, mandatory to seek approval by regulatory authorities for BI 10773 as an anti-diabetic agent compared to an active comparator in patients with…NCT01167881·Phoenix, Arizona and 181 others

TerminatedNGS Screening Protocol to Detect Mutation of KEAP1 or NRF2/NFE2L2 Genes for the KEAPSAKE (CX-839-014) TrialThis is a multicenter screening protocol designed to identify patients with NSCLC who have tumor mutations in the KEAP1 or NRF2/NFE2L2 genes in order to determine potential…NCT04698681·Daphne, Alabama and 62 others

PreviousPage 144 of 831Next

in Arizona

Heart Diseasein Arizona